Ceftaroline-Associated Encephalopathy: A Rare Adverse Effect

Authors

Aswin Srinivasan, HCA HealthcareFollow
Blake Bennie, HCA HealthcareFollow
Krina Viroliya, HCA HealthcareFollow
Ramesh Kesavan, HCA HealthcareFollow
Siva Sarva, HCA HealthcareFollow

Division

Gulf Coast

Hospital

HCA Houston Healthcare Kingwood

Document Type

Case Report

Publication Date

5-1-2021

Keywords

ceftaroline, encephalopathy, drug-related side effects and adverse reactions

Disciplines

Diseases | Internal Medicine | Nervous System Diseases

Abstract

In this case report, we present a patient who suffered ceftaroline-associated encephalopathy, while receiving ceftaroline for acute bacterial skin and skin structure infections (aBSSSIs) that resolved after cessation of the suspected agent. We recommend close monitoring for encephalopathy in patients with creatinine clearance (CrCl) of <50 mL/min receiving ceftaroline.

Publisher or Conference

Cureus

Recommended Citation

Srinivasan A, Bennie B, Viroliya K, Kesavan R, Sarva ST. Ceftaroline-Associated Encephalopathy: A Rare Adverse Effect. Cureus. 2021;13(5):e14795. doi: 10.7759/cureus.14795